Background: We assessed the utility of scintigraphy with indium 111-labeled polyclonal human IgG scintigraphy in patients with fever of unknown origin that fulfilled the criteria of temperature of 38.3 degrees C or more for at least 3 weeks and no diagnosis during 1 week of hospital admission. We compared the utility of this technique with results of scintigraphic techniques reported in the literature.

Methods: Data for all patients seen at our university hospital in whom 111In-IgG scanning was performed were analyzed and checked for the criteria for fever of unknown origin. The literature on the utility of scintigraphic techniques in patients with fever of unknown origin was reviewed.

Results: We studied 24 patients with fever of unknown origin. In 13 patients, focal 111In-IgG accumulation was observed. In nine (38%) of those, the positive 111In-IgG scintigram led to the final diagnosis; in the other four patients (17%), the scintigraphic findings were not helpful. In the 11 patients with negative 111In-IgG scans, extensive diagnostic workup produced no infection as the final diagnosis in nine patients (38%), one had an abscess in a renal cyst that was detected several months later, and in the other the cause of fever was an infected intravenous line. The overall sensitivity and specificity of 111In-IgG scintigraphy were 81% and 69%, respectively. The positive predictive value was 69% and the negative predictive value was 82%.

Conclusions: Our results show that 111In-IgG scintigraphy significantly contributed to the diagnostic process in patients with fever of unknown origin. A positive scan increased the likelihood of finding the cause of the fever, and a negative scan ruled out an inflammatory component with a high degree of certainty. These data compare favorably with data in the literature concerning other radiopharmaceuticals; a larger prospective evaluation of this technique is indicated.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.155.18.1989DOI Listing

Publication Analysis

Top Keywords

fever unknown
24
unknown origin
24
patients fever
20
patients
10
utility scintigraphic
8
fever
8
scintigraphic techniques
8
final diagnosis
8
diagnosis patients
8
111in-igg scintigraphy
8

Similar Publications

() is a bacterium usually present in the gut microbiome of quadruped mammals. is not considered pathogenic for humans; however, several reports have identified it as the etiological agent in cases of chorioamnionitis, postpartum pneumonia and fever of unknown origin. Furthermore, it has been isolated in samples from patients with endocarditis both with and without heart valve replacement.

View Article and Find Full Text PDF

Crohn's disease (CD) causes gastrointestinal symptoms (i.e., diarrhea and abdominal pain), systemic symptoms (i.

View Article and Find Full Text PDF

Melioidosis is a disease endemic to India but often goes unrecognized, leading to considerable illness and death. We present the case of a 31-year-old man who had a fever of unknown origin, abnormal renal and liver function tests, and negative tests for dengue, typhoid, leptospirosis, and scrub typhus. Imaging revealed multiple splenic infarcts.

View Article and Find Full Text PDF

[Perspectives in internal medicine].

Rev Med Suisse

January 2025

Service de médecine interne générale, Département de médecine, Hôpitaux universitaires de Genève, 1211 Genève 14.

Through the analysis of notable studies from 2024, this article offers an overview of key advances in internal medicine with a selection of essential themes. The topics covered include advances in common internal medicine conditions such as cardiovascular diseases, pulmonary disorders, antibiotic use, and fever of unknown origin. This article provides a practical summary to help clinicians stay informed about the latest diagnostic and therapeutic developments.

View Article and Find Full Text PDF

Background: Given the limited available data about to the number of vaccine doses administered over an extended time in Iran, the immune status of vaccinated individuals and any potential disparities in this regard among those who received different numbers of vaccine doses remain unknown. Therefore, this study aimed to assess humoral immunity of individuals who received different doses of the COVID-19 vaccines in Iran.

Methods: This study was conducted from February, 2022 to December 2023 including 605 vaccinated subjects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!